М. С. Шеремета
106 works · 152 citations · h-index 7
Top works
- Federal clinical recommendations on diagnostics and treatment of endocrine ophthalmopathy associated with autoimmune thyroid pathology
- Preparation for radioiodine therapy in patients with differentiated thyroid cancer: a modern perspective (a review)
- Thyrotoxicosis in a patient with Turner syndrome: radioactive iodine therapy
- Clinical practice guidelines for acute and chronic thyroiditis (excluding autoimmune thyroiditis)
- Alemtuzumab-induced Graves’ disease
- Personalized diagnostics of chromaffin tumors (pheochromocytoma, paraganglioma) in oncoendocrinology
- Anti-TSH receptor antibodies as predictors of the severity and outcome of endocrine ophthalmopathy in the patients presenting with Graves' disease
- Thyroid scintigraphy in diagnosis of nodular and diffuse thyroid pathology
- Efficacy and safety of radioiodine treatment of Graves’ disease in children and adolescents
- The use of radioactive substances in medicine — history and development prospects
- Radioactive iodine in the treatment of Graves' disease: history and modern concept of radionuclide therapy
- Autoantibodies, immunoglobulins and cytokine profile in patients with graves' disease and Graves' orbitopathy
- Predictors of the efficacy of radioiodine therapy of Graves’ disease in children and adolescents
- Estimated Inpatient Hospital Stay in Individual Wards: Guidelines on Radiation Safety after Radioiodine Therapy
- Radioiodine therapy activity 550 MBq of I131 in thyrotoxicosis patients
- Thyroid volume is the key predictor of hyperthyroidism remission after radioactive iodine therapy in pediatric patients
- Radioiodine therapy of thyrotoxicosis in children and adolescents. Indications, efficacy and safety. Literature review
- Endocrine disruptors in the pathogenesis of socially significant diseases such as diabetes mellitus, malignant neoplasms, cardiovascular diseases, pathology of the reproductive system
- Treatment of ACTH-ectopic syndrome with long-acting octreotide: effective control of disease activity
- Treatment of Graves’ disease in patients with thyroid eye disease